{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T21:15:46Z","timestamp":1794690946044,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101137235"],"award-info":[{"award-number":["101137235"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nationaal MS fonds","award":["OZ2018-003"],"award-info":[{"award-number":["OZ2018-003"]}]},{"DOI":"10.13039\/501100003000","name":"Stichting MS Research","doi-asserted-by":"publisher","award":["22-1168"],"award-info":[{"award-number":["22-1168"]}],"id":[{"id":"10.13039\/501100003000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Perivascular aggregations of leukocytes, referred to as perivascular cuffs, are a pathological phenomenon in progressive multiple sclerosis (MS). Perivascular cuffing is an exaggerated form of compartmentalized inflammation present in progressive disease. By studying traits of perivascular cuffs, this study aims to elucidate processes within the perivascular niche of the MS brain. We characterized n\u2009=\u2009255 MS donors from the Netherlands Brain Bank for the presence of perivascular cuffs and investigated their association with clinical and pathological donor characteristics. Furthermore, we examined the proportional abundance of different cell types and functional markers in n\u2009=\u2009457 perivascular cuffs present in different lesion stages within a cohort of n\u2009=\u200918 MS brain donors. MS donors with detected perivascular cuffs (25.5%) showed a higher brainstem lesion count. Within these cuffs, there was a relative increase of CD4\n                    <jats:sup>+<\/jats:sup>\n                    compared to CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells, and a higher B-cell abundance in active and mixed active\/inactive MS lesions specifically. All perivascular cuffs were inflammatory active (TNF, PCNA, HLA) and contained antibody-secreting cells, which correlated with the presence of CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. In a different cohort, CNS-isolated viable B cells tested positive for EBV with qPCR (6\/6 MS donors). In these donors, EBV\/LMP-1\n                    <jats:sup>+<\/jats:sup>\n                    B cells were detected in the meninges. In the cuffing cohort, LMP-1\n                    <jats:sup>+<\/jats:sup>\n                    B cells were only present sparsely (13\/122 perivascular cuffs of 6\/11 donors). Lastly, Bruton\u2019s tyrosine kinase (BTK) was abundant in B cells and macrophages within all perivascular cuffs. Our comprehensive characterization of perivascular cuffs in advanced MS links them with disease severity and supports a local interaction between CD4\n                    <jats:sup>+<\/jats:sup>\n                    T and B cells to be associated with lesion presence. Our data indicate that this can happen irrespective of local EBV presence, and supports the targetability of perivascular cuffs by brain-penetrating BTK inhibitors.\n                  <\/jats:p>","DOI":"10.1186\/s40478-025-02208-4","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T21:58:28Z","timestamp":1770328708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["B-cell abundance in perivascular cuffs associates with local lesion activity in multiple sclerosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Hendrik J.","family":"Engelenburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esm\u00e9e","family":"Westenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline","family":"Runderkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin M.","family":"van Luijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chih","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Huitinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Hamann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Smolders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,5]]},"reference":[{"key":"2208_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ et al (2014) Defining the clinical course of multiple sclerosis. Neurology 83:278\u2013286. https:\/\/doi.org\/10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"key":"2208_CR2","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/SCIENCE.AAV7188","volume":"365","author":"NA Patsopoulos","year":"2019","unstructured":"Patsopoulos NA, Baranzini SE, Santaniello A, Shoostari P, Cotsapas C, Wong G et al (2019) Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science 365:eaav7188. https:\/\/doi.org\/10.1126\/SCIENCE.AAV7188","journal-title":"Science"},{"key":"2208_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/SCIENCE.ABJ8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y et al (2022) Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis. Science 375:296\u2013301. https:\/\/doi.org\/10.1126\/SCIENCE.ABJ8222","journal-title":"Science"},{"key":"2208_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/S00281-022-00926-8","volume":"44","author":"J Smolders","year":"2022","unstructured":"Smolders J, van Luijn MM, Hsiao CC, Hamann J (2022) T-cell surveillance of the human brain in health and multiple sclerosis. Semin Immunopathol 44:855\u2013867. https:\/\/doi.org\/10.1007\/S00281-022-00926-8","journal-title":"Semin Immunopathol"},{"key":"2208_CR5","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1093\/BRAIN\/AWAA117","volume":"143","author":"NL Fransen","year":"2020","unstructured":"Fransen NL, Hsiao CC, Van Der Poel M, Engelenburg HJ, Verdaasdonk K, Vincenten MCJ et al (2020) Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions. Brain 143:1714\u20131730. https:\/\/doi.org\/10.1093\/BRAIN\/AWAA117","journal-title":"Brain"},{"key":"2208_CR6","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1038\/s41467-018-07053-9","volume":"9","author":"J Smolders","year":"2018","unstructured":"Smolders J, Heutinck KM, Fransen NL, Remmerswaal EBM, Hombrink P, ten Berge IJM et al (2018) Tissue-resident memory T cells populate the human brain. Nat Commun 9:4593. https:\/\/doi.org\/10.1038\/s41467-018-07053-9","journal-title":"Nat Commun"},{"key":"2208_CR7","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/brain\/awp070","volume":"132","author":"JM Frischer","year":"2009","unstructured":"Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M et al (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132:1175\u20131189. https:\/\/doi.org\/10.1093\/brain\/awp070","journal-title":"Brain"},{"key":"2208_CR8","doi-asserted-by":"publisher","first-page":"e955","DOI":"10.1212\/NXI.0000000000000955","volume":"8","author":"NL Fransen","year":"2021","unstructured":"Fransen NL, de Jong BA, He\u00df K, Kuhlmann T, Vincenten MCJ, Hamann J et al (2021) Absence of B cells in brainstem and white matter lesions associates with less severe disease and absence of oligoclonal bands in MS. Neurol Neuroimmunol Neuroinflamm 8:e955. https:\/\/doi.org\/10.1212\/NXI.0000000000000955","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2208_CR9","doi-asserted-by":"publisher","first-page":"104465","DOI":"10.1016\/j.xcrm.2025.102027","volume":"89","author":"L Bogers","year":"2023","unstructured":"Bogers L, Engelenburg HJ, Janssen M, Unger PPA, Melief MJ, Wierenga-Wolf AF et al (2023) Selective emergence of antibody-secreting cells in the multiple sclerosis brain. EBioMedicine 89:104465. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104465","journal-title":"EBioMedicine"},{"key":"2208_CR10","doi-asserted-by":"publisher","first-page":"102027","DOI":"10.1016\/J.XCRM.2025.102027","volume":"6","author":"I Jelcic","year":"2025","unstructured":"Jelcic I, Naghavian R, Fanaswala I, Macnair W, Esposito C, Calini D et al (2025) T-bet+\u2009CXCR3+\u2009B cells drive hyperreactive B\u2013T cell interactions in multiple sclerosis. Cell Rep Med 6:102027. https:\/\/doi.org\/10.1016\/J.XCRM.2025.102027","journal-title":"Cell Rep Med"},{"key":"2208_CR11","first-page":"467","volume":"81","author":"R Tanaka","year":"1975","unstructured":"Tanaka R, Iwasaki Y, Koprowski H (1975) Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. Am J Pathol 81:467\u2013478","journal-title":"Am J Pathol"},{"key":"2208_CR12","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1093\/BRAIN\/117.4.759","volume":"117","author":"T Revesz","year":"1994","unstructured":"Revesz T, Kidd D, Thompson AJ, Barnard RO, Mcdonald WI (1994) A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain 117:759\u2013765. https:\/\/doi.org\/10.1093\/BRAIN\/117.4.759","journal-title":"Brain"},{"key":"2208_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/S00401-024-02742-W","volume":"147","author":"A de Boer","year":"2024","unstructured":"de Boer A, van den Bosch AMR, Mekkes NJ, Fransen NL, Dagkesamanskaia E, Hoekstra E et al (2024) Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions. Acta Neuropathol 147:90. https:\/\/doi.org\/10.1007\/S00401-024-02742-W","journal-title":"Acta Neuropathol"},{"key":"2208_CR14","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3389\/fimmu.2018.00515","volume":"9","author":"DJ Topham","year":"2018","unstructured":"Topham DJ, Reilly EC (2018) Tissue-resident memory CD8+\u2009T cells: from phenotype to function. Front Immunol 9:515. https:\/\/doi.org\/10.3389\/fimmu.2018.00515","journal-title":"Front Immunol"},{"key":"2208_CR15","doi-asserted-by":"publisher","first-page":"e1154","DOI":"10.1212\/NXI.0000000000001154","volume":"9","author":"A van den Bosch","year":"2022","unstructured":"van den Bosch A, Fransen N, Mason M, Rozemuller AJ, Teunissen C, Smolders J et al (2022) Neurofilament light chain levels in multiple sclerosis correlate with lesions containing foamy macrophages and with acute axonal damage. Neurol Neuroimmunol Neuroinflamm 9:e1154. https:\/\/doi.org\/10.1212\/NXI.0000000000001154","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2208_CR16","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s00401-018-1818-y","volume":"135","author":"S Luchetti","year":"2018","unstructured":"Luchetti S, Fransen NL, van Eden CG, Ramaglia V, Mason M, Huitinga I (2018) Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis. Acta Neuropathol 135:511\u2013528. https:\/\/doi.org\/10.1007\/s00401-018-1818-y","journal-title":"Acta Neuropathol"},{"key":"2208_CR17","doi-asserted-by":"publisher","first-page":"105785","DOI":"10.1016\/J.ISCI.2022.105785","volume":"26","author":"CC Hsiao","year":"2023","unstructured":"Hsiao CC, Engelenburg HJ, Jongejan A, Zhu J, Zhang B, Mingueneau M et al (2023) Osteopontin associates with brain TRM-cell transcriptome and compartmentalization in donors with and without multiple sclerosis. iScience 26:105785. https:\/\/doi.org\/10.1016\/J.ISCI.2022.105785","journal-title":"iScience"},{"key":"2208_CR18","doi-asserted-by":"publisher","first-page":"eadp8109","DOI":"10.1126\/SCITRANSLMED.ADP8109","volume":"17","author":"A Pignata","year":"2025","unstructured":"Pignata A, Frieser D, Gonzalez-Fierro C, Hsiao CC, Engelenburg HJ, Alis M et al (2025) Tissue-resident memory CD4+\u2009T cells infiltrate the CNS in progressive multiple sclerosis and contribute to chronic autoimmunity in mice. Sci Transl Med 17:eadp8109. https:\/\/doi.org\/10.1126\/SCITRANSLMED.ADP8109","journal-title":"Sci Transl Med"},{"key":"2208_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40478-017-0418-8","volume":"5","author":"MR Mizee","year":"2017","unstructured":"Mizee MR, Miedema SSM, van der Poel M, Adelia, Schuurman KG, van Strien ME et al (2017) Isolation of primary microglia from the human post-mortem brain: effects of ante- and post-mortem variables. Acta Neuropathol Commun 5:16. https:\/\/doi.org\/10.1186\/s40478-017-0418-8","journal-title":"Acta Neuropathol Commun"},{"key":"2208_CR20","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/EJI.202048739","volume":"51","author":"J van Langelaar","year":"2021","unstructured":"van Langelaar J, Wierenga-Wolf AF, Samijn JPA, Luijks CJM, Siepman TA, van Doorn PA et al (2021) The association of Epstein\u2013Barr virus infection with CXCR3+\u2009B-cell development in multiple sclerosis: impact of immunotherapies. Eur J Immunol 51:626\u2013633. https:\/\/doi.org\/10.1002\/EJI.202048739","journal-title":"Eur J Immunol"},{"key":"2208_CR21","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1038\/s41467-024-46068-3","volume":"15","author":"AMR van den Bosch","year":"2024","unstructured":"van den Bosch AMR, van der Poel M, Fransen NL, Vincenten MCJ, Bobeldijk AM, Jongejan A et al (2024) Profiling of microglia nodules in multiple sclerosis reveals propensity for lesion formation. Nat Commun 15:1667. https:\/\/doi.org\/10.1038\/s41467-024-46068-3","journal-title":"Nat Commun"},{"key":"2208_CR22","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1084\/JEM.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P et al (2007) Dysregulated Epstein\u2013Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899. https:\/\/doi.org\/10.1084\/JEM.20071030","journal-title":"J Exp Med"},{"key":"2208_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41579-025-01181-y","volume":"23","author":"C M\u00fcnz","year":"2025","unstructured":"M\u00fcnz C (2025) Epstein\u2013Barr virus pathogenesis and emerging control strategies. Nat Rev Microbiol 23:667\u2013679. https:\/\/doi.org\/10.1038\/s41579-025-01181-y","journal-title":"Nat Rev Microbiol"},{"key":"2208_CR24","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrc3702","volume":"14","author":"RW Hendriks","year":"2014","unstructured":"Hendriks RW, Yuvaraj S, Kil LP (2014) Targeting Bruton\u2019s tyrosine kinase in B cell malignancies. Nat Rev Cancer 14:219\u2013232. https:\/\/doi.org\/10.1038\/nrc3702","journal-title":"Nat Rev Cancer"},{"key":"2208_CR25","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1056\/NEJMoa2415988","volume":"392","author":"RJ Fox","year":"2025","unstructured":"Fox RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, Giovannoni G, Vermersch P et al (2025) Tolebrutinib in nonrelapsing secondary progressive multiple sclerosis. N Engl J Med 392:1883\u20131892. https:\/\/doi.org\/10.1056\/NEJMoa2415988","journal-title":"N Engl J Med"},{"key":"2208_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ANA.26870","volume":"95","author":"R Nicholas","year":"2024","unstructured":"Nicholas R, Magliozzi R, Marastoni D, Howell O, Roncaroli F, Muraro P et al (2024) High levels of perivascular inflammation and active demyelinating lesions at time of death associated with rapidly progressive multiple sclerosis disease course: a retrospective postmortem cohort study. Ann Neurol 95:706\u2013719. https:\/\/doi.org\/10.1002\/ANA.26870","journal-title":"Ann Neurol"},{"key":"2208_CR27","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1212\/NXI.0000000000001108","volume":"9","author":"M Moccia","year":"2022","unstructured":"Moccia M, Haider L, Eshaghi A, Van De Pavert SHP, Morra VB, Patel A et al (2022) B cells in the CNS at postmortem are associated with worse outcome and cell types in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 9:e1108. https:\/\/doi.org\/10.1212\/NXI.0000000000001108","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2208_CR28","doi-asserted-by":"publisher","unstructured":"van den Bosch AMR, Khoo JH, Lu Z, Liang H, Wever D, Pu L et al (2024) Microglial States determine lesion dynamics in multiple sclerosis. bioRxiv 2024.10.25.620251. https:\/\/doi.org\/10.1101\/2024.10.25.620251","DOI":"10.1101\/2024.10.25.620251"},{"key":"2208_CR29","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/NATURE10251","volume":"476","author":"S Sawcer","year":"2011","unstructured":"Sawcer S, Hellenthal G, Pirinen M, Spencer CCA, Patsopoulos NA, Moutsianas L et al (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476:214\u2013219. https:\/\/doi.org\/10.1038\/NATURE10251","journal-title":"Nature"},{"key":"2208_CR30","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/BRAIN\/AWY069","volume":"141","author":"J Van Langelaar","year":"2018","unstructured":"Van Langelaar J, Van Vries DV, Janssen RM, Wierenga-Wolf M, Spilt AF, Siepman IM TA et al (2018) T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention. Brain 141:1334\u20131349. https:\/\/doi.org\/10.1093\/BRAIN\/AWY069","journal-title":"Brain"},{"key":"2208_CR31","doi-asserted-by":"publisher","first-page":"2350544","DOI":"10.1002\/EJI.202350544","volume":"54","author":"C Hoeks","year":"2024","unstructured":"Hoeks C, van Puijfelik F, Koetzier SC, Rip J, Corsten CEA, Wierenga-Wolf AF et al (2024) Differential Runx3, Eomes, and T-bet expression subdivides MS-associated CD4+\u2009T cells with brain-homing capacity. Eur J Immunol 54:2350544. https:\/\/doi.org\/10.1002\/EJI.202350544","journal-title":"Eur J Immunol"},{"key":"2208_CR32","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/J.CELL.2018.08.011","volume":"175","author":"I Jelcic","year":"2018","unstructured":"Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I et al (2018) Memory B cells activate brain-homing, autoreactive CD4+\u2009T cells in multiple sclerosis. Cell 175:85\u2013100e23. https:\/\/doi.org\/10.1016\/J.CELL.2018.08.011","journal-title":"Cell"},{"key":"2208_CR33","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/J.MEDJ.2021.01.006","volume":"2","author":"M Kaufmann","year":"2021","unstructured":"Kaufmann M, Evans H, Schaupp AL, Engler JB, Kaur G, Willing A et al (2021) Identifying CNS-colonizing T cells as potential therapeutic targets to prevent progression of multiple sclerosis. Med 2:296\u2013312e8. https:\/\/doi.org\/10.1016\/J.MEDJ.2021.01.006","journal-title":"Med"},{"key":"2208_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMOA1601277","volume":"376","author":"SL Hauser","year":"2017","unstructured":"Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung H-P, Hemmer B et al (2017) Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis. N Engl J Med 376:221\u2013234. https:\/\/doi.org\/10.1056\/NEJMOA1601277","journal-title":"N Engl J Med"},{"key":"2208_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMOA1606468","volume":"376","author":"X Montalban","year":"2017","unstructured":"Montalban X, Hauser S, Kappos L, Arnold D, Bar-Or A, Comi G et al (2017) Ocrelizumab versus placebo in primary progressive multiple sclerosis. N Engl J Med 376:30\u201331. https:\/\/doi.org\/10.1056\/NEJMOA1606468","journal-title":"N Engl J Med"},{"key":"2208_CR36","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/BRAIN\/AWR182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM et al (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134:2755\u20132771. https:\/\/doi.org\/10.1093\/BRAIN\/AWR182","journal-title":"Brain"},{"key":"2208_CR37","doi-asserted-by":"publisher","first-page":"e151683","DOI":"10.1172\/JCI.INSIGHT.151683","volume":"7","author":"SM Ahmed","year":"2022","unstructured":"Ahmed SM, Fransen NL, Touil H, Michailidou I, Huitinga I, Gommerman JL et al (2022) Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosis. JCI Insight 7:e151683. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.151683","journal-title":"JCI Insight"},{"key":"2208_CR38","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.4049\/JIMMUNOL.2000130","volume":"205","author":"M van der Poel","year":"2020","unstructured":"van der Poel M, Hoepel W, Hamann J, Huitinga I, Dunnen Jden (2020) IgG immune complexes break immune tolerance of human microglia. J Immunol 205:2511\u20132518. https:\/\/doi.org\/10.4049\/JIMMUNOL.2000130","journal-title":"J Immunol"},{"key":"2208_CR39","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/ACN3.52009","volume":"11","author":"S El Mahdaoui","year":"2024","unstructured":"El Mahdaoui S, Hansen MM, von Essen MR, Hvalkof VH, Holm Hansen R, Mahler MR et al (2024) CD11c+\u2009B cells in relapsing\u2013remitting multiple sclerosis and effects of anti-CD20 therapy. Ann Clin Transl Neurol 11:926. https:\/\/doi.org\/10.1002\/ACN3.52009","journal-title":"Ann Clin Transl Neurol"},{"key":"2208_CR40","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/brain\/awy151","volume":"141","author":"J Machado-Santos","year":"2018","unstructured":"Machado-Santos J, Saji E, Tr\u00f6scher AR, Paunovic M, Liblau R, Gabriely G et al (2018) The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+\u2009T lymphocytes and B cells. Brain 141:2066\u20132082. https:\/\/doi.org\/10.1093\/brain\/awy151","journal-title":"Brain"},{"key":"2208_CR41","doi-asserted-by":"publisher","first-page":"e550","DOI":"10.1212\/NXI.0000000000000550","volume":"6","author":"JA Benjamins","year":"2019","unstructured":"Benjamins JA, Nedelkoska L, Touil H, Stemmer PM, Carruthers NJ, Jena BP et al (2019) Exosome-enriched fractions from MS B cells induce oligodendrocyte death. Neurol Neuroimmunol Neuroinflamm 6:e550. https:\/\/doi.org\/10.1212\/NXI.0000000000000550","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2208_CR42","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.1093\/brain\/awac232","volume":"145","author":"RE James Bates","year":"2022","unstructured":"James Bates RE, Browne E, Schalks R, Jacobs H, Tan L, Parekh P et al (2022) Lymphotoxin-alpha expression in the meninges causes lymphoid tissue formation and neurodegeneration. Brain 145:4287\u20134307. https:\/\/doi.org\/10.1093\/brain\/awac232","journal-title":"Brain"},{"key":"2208_CR43","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1093\/BRAIN\/AWP296","volume":"133","author":"LAN Peferoen","year":"2010","unstructured":"Peferoen LAN, Lamers F, Lodder LNR, Gerritsen WH, Huitinga I, Melief J et al (2010) Epstein barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 133:e137. https:\/\/doi.org\/10.1093\/BRAIN\/AWP296","journal-title":"Brain"},{"key":"2208_CR44","doi-asserted-by":"publisher","first-page":"e2425670122","DOI":"10.1073\/PNAS.2425670122","volume":"122","author":"N Orr","year":"2025","unstructured":"Orr N, Steinman L (2025) Epstein\u2013Barr virus and the immune microenvironment in multiple sclerosis: insights from high-dimensional brain tissue imaging. Proc Natl Acad Sci USA 122:e2425670122. https:\/\/doi.org\/10.1073\/PNAS.2425670122","journal-title":"Proc Natl Acad Sci USA"},{"key":"2208_CR45","doi-asserted-by":"publisher","first-page":"e466","DOI":"10.1212\/NXI.0000000000000466","volume":"5","author":"MA Moreno","year":"2018","unstructured":"Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L et al (2018) Molecular signature of Epstein\u2013Barr virus infection in MS brain lesions. Neurol Neuroimmunol Neuroinflamm 5:e466. https:\/\/doi.org\/10.1212\/NXI.0000000000000466","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2208_CR46","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41579-019-0249-7","volume":"17","author":"C M\u00fcnz","year":"2019","unstructured":"M\u00fcnz C (2019) Latency and lytic replication in Epstein\u2013Barr virus-associated oncogenesis. Nat Rev Microbiol 2019 17:11. https:\/\/doi.org\/10.1038\/s41579-019-0249-7","journal-title":"Nat Rev Microbiol 2019"},{"key":"2208_CR47","doi-asserted-by":"publisher","first-page":"e160909","DOI":"10.1172\/JCI.INSIGHT.160909","volume":"7","author":"L Rijvers","year":"2022","unstructured":"Rijvers L, van Langelaar J, Bogers L, Melief MJ, Koetzier SC, Blok KM et al (2022) Human T-bet+\u2009B cell development is associated with BTK activity and suppressed by evobrutinib. JCI Insight 7:e160909. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.160909","journal-title":"JCI Insight"},{"key":"2208_CR48","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa2415985","volume":"392","author":"J Oh","year":"2025","unstructured":"Oh J, Arnold DL, Cree BAC, Ionete C, Kim HJ, Sormani MP et al (2025) Tolebrutinib versus teriflunomide in relapsing multiple sclerosis. N Engl J Med 392:1893\u20131904. https:\/\/doi.org\/10.1056\/NEJMoa2415985","journal-title":"N Engl J Med"},{"key":"2208_CR49","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/S12974-024-03267-5","volume":"21","author":"J Langlois","year":"2024","unstructured":"Langlois J, Lange S, Ebeling M, Macnair W, Schmucki R, Li C et al (2024) Fenebrutinib, a Bruton\u2019s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways. J Neuroinflamm 21:276. https:\/\/doi.org\/10.1186\/S12974-024-03267-5","journal-title":"J Neuroinflamm"},{"key":"2208_CR50","doi-asserted-by":"publisher","first-page":"104789","DOI":"10.1016\/J.EBIOM.2023.104789","volume":"96","author":"H Touil","year":"2023","unstructured":"Touil H, Li R, Zuroff L, Moore CS, Healy L, Cignarella F et al (2023) Cross-talk between B cells, microglia and macrophages, and implications to central nervous system compartmentalized inflammation and progressive multiple sclerosis. EBioMedicine 96:104789. https:\/\/doi.org\/10.1016\/J.EBIOM.2023.104789","journal-title":"EBioMedicine"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02208-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02208-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02208-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:37:44Z","timestamp":1781631464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40478-025-02208-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,5]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2208"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02208-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,5]]},"assertion":[{"value":"5 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was given by the donors for brain autopsy and for the use of material and clinical data for research purposes in compliance with national guidelines. The NBB autopsy procedures were approved by the Medical Ethics Committee of the VU Medical Center, Amsterdam, The Netherlands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"H.J.E., E.W., E.R, A.M.M., M.M.v.L., C.-C.H. have nothing to report. I.H. received speaker honoraria or consultancy fees from Biogen, MUNA Therapeutics and Novartis. J.H. received research support from Biogen. J.S. received research support from Biogen, Roche, Siemens Healthineers, and Hansa Biopharma, and received speaker honoraria or consultancy fees from Biogen, Merck, Novartis, Roche and Sanofi.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}